These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8280429)

  • 1. Antigenic evidence of the presence of the aberrant HIV-1ant70 virus in Cameroon and Gabon.
    Nkengasong JN; Peeters M; vanden Haesevelde M; Musi SS; Willems B; Ndumbe PM; Delaporte E; Perret JL; Piot P; van den Groen G
    AIDS; 1993 Nov; 7(11):1536-8. PubMed ID: 8280429
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of linear antigenic epitopes on GP120 encoded in sibling clones of novel New York HIV-1 subtype B isolates.
    Riley JP; Pestano GA; Harewood K; Alfred LJ; Guyden J; Boto WM
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S83-91. PubMed ID: 8574151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational preferences of a chimeric peptide HIV-1 immunogen from the C4-V3 domains of gp120 envelope protein of HIV-1 CAN0A based on solution NMR: comparison to a related immunogenic peptide from HIV-1 RF.
    Vu HM; de Lorimier R; Moody MA; Haynes BF; Spicer LD
    Biochemistry; 1996 Apr; 35(16):5158-65. PubMed ID: 8611499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the immunologic heterogeneity of HIV-1. II. Effect of amino acid residues, flanking the C-terminus of the central tetrapeptide loop V3 of gp120].
    Shchelkanov MIu; Iaroslavtseva NG; Iudin AN; Eremin VF; Pyzhova NS; Semiletov IuA; Abélian AV; Titov LP; Karamov EV
    Mol Biol (Mosk); 1998; 32(4):729-34. PubMed ID: 9785579
    [No Abstract]   [Full Text] [Related]  

  • 5. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of amino acid substitutions in the gp120 V3-loop sequence on serological cross-reactivity between various HIV-1 subtypes].
    Iaroslavtseva NG; Shchelkanov MIu; Iudin AN; Navruzbekov GA; Semiletov IuA; Karamov EV
    Mol Biol (Mosk); 1997; 31(2):338-43. PubMed ID: 9213763
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies].
    Shchelkanov MIu; Iaroslavtseva NG; Emel'ianov AV; Sakhuriia IB; Abélian AV; Verevochkin SV; Kozlov AP; Karamov EV
    Mol Biol (Mosk); 1998; 32(6):1062-74. PubMed ID: 9929887
    [No Abstract]   [Full Text] [Related]  

  • 10. B cell antigenic site mapping of HIV-1 glycoproteins.
    Neurath AR
    Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
    [No Abstract]   [Full Text] [Related]  

  • 11. [Theoretical study of peptide spatial structure--fragments of the base antigenic determinant of HIV-1 gp120 protein. I. Peptides rp142 and rp342].
    Andrianov AM
    Mol Biol (Mosk); 1997; 31(5):861-71. PubMed ID: 9454072
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy.
    Wang FX; Kimura T; Nishihara K; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2002 Mar; 185(5):608-17. PubMed ID: 11865417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera.
    Lawoko AL; Johansson B; Hjalmarsson S; Christensson B; Ljungberg B; Al-Khalili L; Sjölund M; Pipkorn R; Fenyö EM; Blomberg J
    J Med Virol; 1999 Oct; 59(2):169-79. PubMed ID: 10459152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of HIV-1 subtypes: implications for vaccine formulations.
    Smith TL; van Rensburg EJ; Engelbrecht S
    J Med Virol; 1998 Nov; 56(3):264-8. PubMed ID: 9783696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.
    Rosen O; Chill J; Sharon M; Kessler N; Mester B; Zolla-Pazner S; Anglister J
    Biochemistry; 2005 May; 44(19):7250-8. PubMed ID: 15882063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence of the presence of genetically aberrant HIV-1 strains in Cameroon and Gabon.
    Janssens W; Nkengasong JN; Heyndrickx L; Fransen K; Ndumbe PM; Delaporte E; Peeters M; Perret JL; Ndoumou A; Atende C
    AIDS; 1994 Jul; 8(7):1012-3. PubMed ID: 7946088
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the V3 loop of gp120 in HIV infection.
    Moore JP; Nara PL
    AIDS; 1991; 5 Suppl 2():S21-33. PubMed ID: 1845049
    [No Abstract]   [Full Text] [Related]  

  • 20. A serologic analysis and the amino acid sequence of the V3 region of human immunodeficiency virus from carriers in Bangkok.
    Okuda K; Bukawa H; Kawamoto S; Imai M; Saito T; Phanuphak P; Hamajima K
    J Infect Dis; 1994 Jan; 169(1):227-8. PubMed ID: 8277190
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.